Chimeric Therapies Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3
Founded: Laguna Niguel CA United States (1996)
Status: Defunct (2001)

Organization Overview

First Clinical Trial
2000
NCT00004255
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

Chimeric Therapeutics

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Graft vs Host Disease (Phase 3)

Leukemia (Phase 3)

Myelodysplastic Syndromes (Phase 3)

Preleukemia (Phase 3)

Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 10